Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study

By                          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 433-441

Spandidos Publications

Access to resources Recommend Favorite

Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review)

By Ueda Hiroki   Fukuchi Hiroko   Tanaka Chigusa  

Oncology Letters, Vol. 3, Iss. 2, 2012-02 ,pp. : 259-263

Spandidos Publications

Access to resources Recommend Favorite

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma

By Kim Beom   Park Jun   Choi Hye   Kim Do   Ahn Sang   Kim Ja   Lee Do   Lee Kwang   Han Kwang-Hyub  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 659-667

Springer Publishing Company

Access to resources Recommend Favorite

Rapid and early αfetoprotein and desγcarboxy prothrombin responses to initial arterial infusion chemotherapy predict treatment outcomes of advanced hepatocellular carcinoma

By                            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 655-662

Science Publishers

Access to resources Recommend Favorite

Comparison of standard-dose and halfdose sorafenib therapy on clinical outcome in patients with unresectable hepatocellular carcinoma in field practice: A propensity score matching analysis

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2295-2302

Spandidos Publications

Access to resources Recommend Favorite